K.D. Kamtekar

Efficacy of a 14-day primaquine regimen in preventing relapses in patients with Plasmodium vivax malaria in Mumbai, India

Dimple Rajgor, N. J. Gogtay, V. S. Kadam et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 2003 · 33 citations

Plasmodium Vivax Malaria, Antirelapse Therapy, Global Health +12

A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587]

NJ Gogtay, K.D. Kamtekar, Dalvi Ss et al. · BMC Infectious Diseases · 2006 · 27 citations · Full text

Efficacies of 5- and 14-day primaquine regimens in the prevention of relapses in<i>Plasmodium vivax</i>infections

Nithya Gogtay, Saaketh Desai, K.D. Kamtekar et al. · Annals of Tropical Medicine and Parasitology · 1999 · 23 citations

14-Day Primaquine Regimens, World Health Organization, Abstractvivax Malaria Accounts +12

Probable resistance to parenteral artemether in <i>Plasmodium falciparum</i>: case reports from Mumbai (Bombay), India

N. J. Gogtay, V. S. Kadam, Dilip R. Karnad et al. · Annals of Tropical Medicine and Parasitology · 2000 · 22 citations

Antiparasitic Agent, Malaria, Clinical Epidemiology +9

A 5 days primaquine regimen as anti-relapse therapy for Plasmodium vivax

Nithya Gogtay, Mamta Garg, V. S. Kadam et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 1998 · 19 citations

Clinical Therapeutic, Antiparasitic Agent, Malaria +11